TP53 and type 2 diabetes mellitus: The top eleven (11) pathways identified through this approach were: Insulin Receptor Signaling, Type II Diabetes Mellitus Signaling, Apoptosis Signaling, Aryl Hydrocarbon Receptor Signaling, p53 Signaling, Mitochondrial Dysfunction, Chronic Myeloid Leukemia Signaling, Parkinson’s Signaling, Molecular Mechanism of Cancer, Glioma Signaling, and Cell Cycle G1/S Checkpoint Regulation (Figure 2).